Pharma’s Almanac Most Impactful Thought Leadership of 2018

2018 YEAR IN REVIEW

As we look forward to another year of illuminating Thought Leadership content at Pharma’s Almanac, we wanted to reflect on 2018 and highlight a selection of articles and authors that had the greatest measurable impact on our readers. We strive to publish the most thought-provoking, original content on diverse topics that are challenging and changing the pharmaceutical industry, particularly showcasing supporting outsourcing providers. 

Through our Analytics suite available on PharmasAlmanac.com, we are able to capture data on the traffic through our content portal. This includes the articles, companies, contributors and topics that have received the most views among our audience of industry professionals. 

Here, we present some of this digital data analysis for readers of our print magazine, showcasing the most-read articles across the entire pharmaceutical supply chain (from CDMOs, CROs, excipients, equipment and logistics), as well as specific industry segments and specialty topics of interest.

Among our own content authored by members of the Nice Insight team, we had the greatest impact with the three-part features from our first and second quarter issues of Pharma’s Almanac, which explored mergers and acquisitions activity and next-generation biologics therapies, respectively.

Additionally, we are highlighting the companies and individual contributors who have generated the most interactions on our site over the last year, as well as the trending topics that have made the greatest overall impressions in the first quarter of 2019. 

We are proud to have had the privilege of developing and publishing such a diversity of insightful Thought Leadership content covering subjects of the highest value to our readers throughout pharma and supporting industries, and we are enthusiastic about the opportunity to continue to support our community as the industry continues to evolve in 2019 and beyond.


Top Articles on Specialty Topics

Encapsulation: Overcoming Formulation Challenges with Liquid-fill Capsules,” Eli Elias, CapsCanada

Artificial Intelligence:Artificial Intelligence in Biopharmaceutical Manufacturing,” Constantin Loghinov, MILS Group LLC

M&A: Inside Mergers & Acquisitions,” Kevin Bottomley, Results Healthcare

Parenterals:Expanding U.S. Supply Options for Large-Volume Parenterals,” Marga Viñes, Grifols

Formulation:The Coming of Age of Amorphous Solid Dispersions,” Márcio Temtem, Ph.D., Hovione

OSD: Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing,” Ariana Nagel & Matthew Ferrell, UPM Pharmaceuticals

Fermentation:Focused on Fermentation,” Elise Mous & Thomas De Maria, Capua Bioservices


Top Articles by Industry Segment

API:  "Meeting the Need for Small-Volume API Manufacturing,” Jim Scandura, Avara Pharmaceutical Services

Biologics: "Fully Supporting Customer Needs for Biologics Development and Manufacturing,” James Park, Samsung Biologics

Cell & Gene Therapy:  "Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing,” Richard Snyder, Ph.D., Christopher Murphy, Susan D’Costa  Ph.D., & Cameron Jones, Brammer Bio

Engineering: "Death to Cleanrooms in Biopharmaceutical Manufacturing,” Mark Pelletier, Ph.D., CRB USA

Standalone CDMO:Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services,” Andrea Baiocchi, Avara Pharmaceutical Services

Embedded CDMO:Why Business Continuity Management is Important for CDMOs,” Mayeul Cauvin, Servier 


Top Company Interactions on PharmasAlmanac.com (articles, profiles, etc.)

 

1. Avara Pharmaceutical Services

2. Federal Equipment Company

3. Servier

4. Marken

5. Hovione

6. Alcami

7. UPM Pharmaceuticals

8. CRB USA

9. Brammer Bio

10. CapsCanada

11. BioVectra

12. AMRI

13. Catalent

14. GSK Contract Manufacturing

15. Almac

16.  AbbVie Contract Manufacturing

17. Patheon

18. Grifols

19. Piramal Pharma Solutions

20. WuXi AppTec

 

Q1_Best_of2018_sidebar


Top Articles Across the Supply Chain

CDMO: Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services,” Andrea Baiocchi, Avara Pharmaceutical Services 

CRO: Creating Comprehensive Solutions through Laboratory Testing,” Xin Zhang, Ph.D., WuXi AppTec

Excipients: Investing in New Technologies for Innovative Functional Solutions,” Sarath Chandar, SPI Pharma

Pharma Equipment: Microbial and Biological Decontamination of Equipment Brings Peace of Mind,” Matt Hicks, Federal Equipment Company

Logistics: Overcoming Challenges in the Complex Market for Clinical Trials and Clinical Logistics,” Wes Wheeler, Marken


Trending Topics in the First Quarter of 2019:

+ Parenteral manufacturing

+ CDMO

+ Cell & gene therapy

+ Biologics – large molecule

+ Packaging

+ Innovation

+ Continuous Manufacturing

+ Logistics

+ CRO

+ Automation

+ Regulatory

+ API – small molecule

+ Outsourcing

+ Excipients


Top 10 Contributors to Pharma’s Almanac Overall (not ranked)

Richard Snyder, Ph.D., CSO/Founder, & Mark Bamforth, CEO/Founder, Brammer Bio

Mark Pelletier, Ph.D., Director, CRB USA

Marga Viñes, Business Development Manager, Grifols

Syed T. Husain, CCO, Alcami

Wes Wheeler, CEO, Marken 

Peter Walters, Lead Process Engineer, CRB USA

Ramesh Subramian, VP, Strategic Marketing & Global Head, Business Development, Piramal Pharma Solutions

Andrew Bulpin, Head of Process Solutions Strategic, Marketing and Innovation, Millipore Sigma

Matt Hicks, COO & Counsel, Federal Equipment Company

Doug Krafte, Ph.D., Chief Scientific Officer, Icagen

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.